Dementia & Alzheimer disease

F. Checler received his PhD in Cellular and Molecular Pharmacology from University of Nice-Sophia-Antipolis (1983). Since 1994, he works on neurodegenerative diseases where he was mainly interested in proteolytic dysfunction and cell death mechanisms involved in Alzheimer’s disease then on dysfunctions taking place in Parkinson’s and prion diseases.Nowadays, he is developing an additional project aimed at identifying common molecular pathways either exacerbated or disrupted in neurodegenerative diseases and cerebral cancer. F. Checler belongs to the laboratory of Excellence DistALZ(Development of Innovative STrategies for translational Approach in ALZheimer Disease). He was the first president of the “Ligue Européenne Contre la Maladie d’Alzheimer”.